Eisai
4523.T
#2227
Rank
A$12.39 B
Marketcap
A$43.91
Share price
-0.46%
Change (1 day)
-17.49%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): A$1.31

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.21. In 2026 the company made an earnings per share (EPS) of A$1.21 a decrease over its 2025 EPS that were of A$1.53.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026A$1.21-21.04%
2025A$1.5311.85%
2024A$1.37-32.63%
2023A$2.035.52%
2022A$1.93-74.01%
2021A$7.41-66.58%
2020A$22.1798.24%
2019A$11.1917.01%
2018A$9.5637.78%
2017A$6.94-27.62%
2016A$9.5935.33%
2015A$7.08-2.82%
2014A$7.29-27.66%
2013A$10.08-27.49%
2012A$13.90-12.67%
2011A$15.9288.08%
2010A$8.46-11.06%
2009A$9.51-390.15%
2008A-$3.28-127.78%
2007A$11.81347.11%
2006A$2.644.38%
2005A$2.537.4%
2004A$2.3643.03%
2003A$1.6525.09%
2002A$1.3252.67%
2001A$0.8669.76%
2000A$0.51